Andera Partners
- SEC CIK
- 0001757283
- Latest filing
- Jul 22, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only.
- Positions
- 5
- No filing for Q3 2025
- Portfolio value
- $176.6M
- No filing for Q3 2025
Andera Partners did not file a 13F for Q3 2025, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KMTSKestra Medical Technologies, Ltd. | SHS | 2,540,106 | $67.4M | 38.1% | – | – | History |
| MLYSMineralys Therapeutics, Inc. | COM | 1,591,917 | $57.8M | 32.7% | – | – | History |
| EVMNEvommune, Inc. | COM SHS | 1,897,362 | $32.5M | 18.4% | – | – | History |
| ABVXAbivax S.A. | SPONSORED ADS | 78,125 | $10.5M | 6.0% | – | – | History |
| IVAInventiva S.A. | ADS | 1,818,181 | $8.45M | 4.8% | – | – | History |